# HexafluOride, a Contrast Agent for Placenta Echo-angiography

> **NCT02884297** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Régional Metz-Thionville** · enrollment: 55 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DRUG:** Contrast agent: SonoVue®.

## Key facts

- **NCT ID:** NCT02884297
- **Lead sponsor:** Centre Hospitalier Régional Metz-Thionville
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-12
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2019-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02884297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02884297, "HexafluOride, a Contrast Agent for Placenta Echo-angiography". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02884297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*